Skip to Main Content

Author Details

Christopher B Wilson
Drukier Institute for Children's Health
1976
321
96
PMIDPaper TitleJournal TitlePublished Year
36862518Site of vulnerability on SARS-CoV-2 spike induces broadly protective antibody against antigenically distinct Omicron subvariants.J Clin Invest2023
37603748IgG3 subclass antibodies recognize antigenically drifted influenza viruses and SARS-CoV-2 variants through efficient bivalent binding.Proc Natl Acad Sci U S A2023
37322120Antigen-driven colonic inflammation is associated with development of dysplasia in primary sclerosing cholangitis.Nat Med2023
34669506Human Anti-neuraminidase Antibodies Reduce Airborne Transmission of Clinical Influenza Virus Isolates in the Guinea Pig Model.J Virol2022
35446141Novel Epitopes of the Influenza Virus N1 Neuraminidase Targeted by Human Monoclonal Antibodies.J Virol2022
36206332Severe COVID-19 induces autoantibodies against angiotensin II that correlate with blood pressure dysregulation and disease severity.Sci Adv2022
36203556IgG3 subclass antibodies recognize antigenically drifted influenza viruses and SARS-CoV-2 variants through efficient bivalent binding.bioRxiv2022
35183062Librator: a platform for the optimized analysis, design, and expression of mutable influenza viral antigens.Brief Bioinform2022
34942633Broadly neutralizing antibodies target a haemagglutinin anchor epitope.Nature2022
35243425Teach 'em young: Influenza vaccines induce broadly neutralizing antibodies in children.Cell Rep Med2022
33468695SARS-CoV-2 Infection Severity Is Linked to Superior Humoral Immunity against the Spike.mBio2021
35475142Improved integration of single-cell transcriptome and surface protein expression by LinQ-View.Cell Rep Methods2021
33830176Hemolysis-associated phosphatidylserine exposure promotes polyclonal plasmablast differentiation.J Exp Med2021
33568453Identification and Characterization of Novel Antibody Epitopes on the N2 Neuraminidase.mSphere2021
33593972Mutations in the Hemagglutinin Stalk Domain Do Not Permit Escape from a Protective, Stalk-Based Vaccine-Induced Immune Response in the Mouse Model.mBio2021
33593910Influenza hemagglutinin-specific IgA Fc-effector functionality is restricted to stalk epitopes.Proc Natl Acad Sci U S A2021
33529242Extrafollicular CD4 T cell-derived IL-10 functions rapidly and transiently to support anti-Plasmodium humoral immunity.PLoS Pathog2021
34697321Functionality of the putative surface glycoproteins of the Wuhan spiny eel influenza virus.Nat Commun2021
34811531Mycobiota-induced IgA antibodies regulate fungal commensalism in the gut and are dysregulated in Crohn's disease.Nat Microbiol2021
34781736Cross-Neutralization of Emerging SARS-CoV-2 Variants of Concern by Antibodies Targeting Distinct Epitopes on Spike.mBio2021
34751272SARS-CoV-2 infection induces cross-reactive autoantibodies against angiotensin II.medRxiv2021
34078743First exposure to the pandemic H1N1 virus induced broadly neutralizing antibodies targeting hemagglutinin head epitopes.Sci Transl Med2021
34126773An Egg-Derived Sulfated <i>N</i>-Acetyllactosamine Glycan Is an Antigenic Decoy of Influenza Virus Vaccines.mBio2021
34067435B Cell Responses against Influenza Viruses: Short-Lived Humoral Immunity against a Life-Long Threat.Viruses2021
34312615Cross neutralization of emerging SARS-CoV-2 variants of concern by antibodies targeting distinct epitopes on spike.Res Sq2021
34358128Bridging the B Cell Gap: Novel Technologies to Study Antigen-Specific Human B Cell Responses.Vaccines (Basel)2021
34022127Profiling B cell immunodominance after SARS-CoV-2 infection reveals antibody evolution to non-neutralizing viral targets.Immunity2021
33288923A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trial.Nat Med2021
33034095Clinical predictors of donor antibody titre and correlation with recipient antibody response in a COVID-19 convalescent plasma clinical trial.J Intern Med2021
33169014Proinflammatory IgG Fc structures in patients with severe COVID-19.Nat Immunol2021
31630990Immunogenicity of chimeric haemagglutinin-based, universal influenza virus vaccine candidates: interim results of a randomised, placebo-controlled, phase 1 clinical trial.Lancet Infect Dis2020
31988118High-complexity extracellular barcoding using a viral hemagglutinin.Proc Natl Acad Sci U S A2020
31951517It's Hard to Teach an Old B Cell New Tricks.Cell2020
31733824Aging and influenza vaccine-induced immunity.Cell Immunol2020
33169668Biochemical patterns of antibody polyreactivity revealed through a bioinformatics-based analysis of CDR loops.Elife2020
33329582Machine Learning to Quantify <i>In Situ</i> Humoral Selection in Human Lupus Tubulointerstitial Inflammation.Front Immunol2020
33303605Remembering seasonal coronaviruses.Science2020
33298562Preexisting immunity shapes distinct antibody landscapes after influenza virus infection and vaccination in humans.Sci Transl Med2020
33096040Polyreactive Broadly Neutralizing B cells Are Selected to Provide Defense against Pandemic Threat Influenza Viruses.Immunity2020
32943267Correctly folded - but not necessarily functional - influenza virus neuraminidase is required to induce protective antibody responses in mice.Vaccine2020
32995763Distinct B cell subsets give rise to antigen-specific antibody responses against SARS-CoV-2.Res Sq2020
32935099SARS-CoV-2 infection severity is linked to superior humoral immunity against the spike.bioRxiv2020
32907980Characterization of Novel Cross-Reactive Influenza B Virus Hemagglutinin Head Specific Antibodies That Lack Hemagglutination Inhibition Activity.J Virol2020
32666572Imprinting, immunodominance, and other impediments to generating broad influenza immunity.Immunol Rev2020
32511463Proinflammatory IgG Fc structures in patients with severe COVID-19.medRxiv2020
32287326Characterizing Emerging Canine H3 Influenza Viruses.PLoS Pathog2020
30539468An Efficient Method to Generate Monoclonal Antibodies from Human B Cells.Methods Mol Biol2019
31951584Emerging from the Shadow of Hemagglutinin: Neuraminidase Is an Important Target for Influenza Vaccination.Cell Host Microbe2019
31434733Monoclonal Antibody Responses after Recombinant Hemagglutinin Vaccine versus Subunit Inactivated Influenza Virus Vaccine: a Comparative Study.J Virol2019
31406333The neuraminidase of A(H3N2) influenza viruses circulating since 2016 is antigenically distinct from the A/Hong Kong/4801/2014 vaccine strain.Nat Microbiol2019
  • 1 - 50 of 321

Recommended Authors

Alexander F Rosenberg
University of Alabama at Birmingham Birmingham
Career Start Year 2011
Number of shared co-authors 2
Jacob D Eccles
University of Illinois at Chicago
Career Start Year 2008
Number of shared co-authors 0
Marc Veldhoen
Instituto de Medicina Molecular, Faculdade de Medicina da Universidade de Lisboa
Career Start Year 2005
Number of shared co-authors 3
Pradyot Dash
St. Jude Children's Research Hospital
Career Start Year 2005
Number of shared co-authors 7
Sunil Thomas
Lankenau Institute for Medical Research
Career Start Year 2004
Number of shared co-authors 3
Franklin R Toapanta
University of Maryland School of Medicine
Career Start Year 2004
Number of shared co-authors 1
Subhasis Mohanty
Yale School of Medicine, Yale University
Career Start Year 2002
Number of shared co-authors 0
Martin Prlic
Fred Hutchinson Cancer Research Center
Career Start Year 2001
Number of shared co-authors 1
Paul G Thomas
St. Jude Children's Research Hospital
Career Start Year 2000
Number of shared co-authors 15
Michelle A Gill
University of Rochester Medical Center
Career Start Year 1999
Number of shared co-authors 2
Cristina M Tato
Institute of Immunity, Stanford University School of Medicine
Career Start Year 1998
Number of shared co-authors 1
Chance John Luckey
University of Virginia School of Medicine.
Career Start Year 1995
Number of shared co-authors 0
Akiko Iwasaki
Yale University
Career Start Year 1990
Number of shared co-authors 7
Frances E Lund
The University of Alabama at Birmingham
Career Start Year 1990
Number of shared co-authors 0
P Robert Beatty
School of Public Health, University of California berkeley
Career Start Year 1990
Number of shared co-authors 1
Liise-Anne Pirofski
Albert Einstein College of Medicine, Montefiore Medical Center
Career Start Year 1990
Number of shared co-authors 1
Albert C Shaw
Yale School of Medicine, Yale University
Career Start Year 1987
Number of shared co-authors 0
Gregory A Poland
Mayo Clinic Vaccine Research Group
Career Start Year 1985
Number of shared co-authors 3
Martin S Zand
University of Rochester Medical Center
Career Start Year 1983
Number of shared co-authors 4
Penelope A Morel
University of Pittsburgh
Career Start Year 1982
Number of shared co-authors 4
Rafick-Pierre Sekaly
Pathology Advanced Translational Research Unit, Emory University School of Medicine
Career Start Year 1981
Number of shared co-authors 15
Louis J Picker
Vaccine and Gene Therapy Institute, Oregon Health & Science University
Career Start Year 1980
Number of shared co-authors 6
Merril Gersten
University of California
Career Start Year 1976
Number of shared co-authors 2
James E Crowe
Vanderbilt University Medical Center
Career Start Year 1975
Number of shared co-authors 13
Jonathan Braun
Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center
Career Start Year 1975
Number of shared co-authors 4
Alan C Whitmore
University of North Carolina at Chapel Hill
Career Start Year 1973
Number of shared co-authors 2
Hilary S Warren
Massachusetts General Hospital
Career Start Year 1973
Number of shared co-authors 0
Ronald J Messer
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year 1972
Number of shared co-authors 1
Ronald N Germain
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year 1971
Number of shared co-authors 2
Jay A Berzofsky
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1966
Number of shared co-authors 3

Collaborators

Rafi Ahmed
Co-authored papers 23
Peter Palese
Icahn School of Medicine at Mount Sinai
Co-authored papers 18
Tobias R Kollmann
Telethon Kids Institute
Co-authored papers 11
Adolfo Garc??a-Sastre
Icahn School of Medicine at Mount Sinai
Co-authored papers 9
Yoshihiro Kawaoka
Influenza Research Institute, University of Wisconsin
Co-authored papers 8
Viviana Simon
Icahn School of Medicine at Mount Sinai
Co-authored papers 6
Andrzej Joachimiak
Center for Structural Biology of Infectious Diseases, University of Chicago
Co-authored papers 5
Peter S Linsley
8Benaroya Research Institute
Co-authored papers 5
Paul E Leon
Icahn School of Medicine at Mount Sinai
Co-authored papers 5
Gui-Mei Li
Co-authored papers 5
Harm van Bakel
Icahn School of Medicine at Mount Sinai
Co-authored papers 5
Megan McCausland
Co-authored papers 5
Mark J Mulligan
Co-authored papers 4
Rong Hai
University of California riverside
Co-authored papers 4
Lynda Coughlan
University of Maryland
Co-authored papers 4
Bali Pulendran
Institute for Immunity, Stanford University School of Medicine, Stanford University
Co-authored papers 4
Jeff Furlong
Co-authored papers 3
Luis Martinez-Sobrido
Texas Biomedical Research Institute
Co-authored papers 3
Christopher Chiu
Co-authored papers 3
Harry B Greenberg
Stanford University School of Medicine
Co-authored papers 3
Mario Cortese
Co-authored papers 3
Jamey D Marth
Co-authored papers 3
Ian A Wilson
The Scripps Research Institute, USA The Skaggs Institute for Chemical Biology
Co-authored papers 3
Mark M Davis
Co-authored papers 3
Ted M Ross
Center for Vaccines and Immunology, University of Georgia
Co-authored papers 3
Alan Aderem
Seattle Children's Research Institute
Co-authored papers 3
David Noah Sather
Center for Global Infectious Disease Research, Seattle Children's Hospital
Co-authored papers 3
Aneesh K Mehta
Emory University School of Medicine
Co-authored papers 3
Randy A Albrecht
Icahn School of Medicine at Mount Sinai
Co-authored papers 3
Skye Spencer
Co-authored papers 2
Release 1.2